4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001641172-25-003824
Options or other derivatives
- Chief Executive Officer returned 13,626 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Meckler Jeffrey A · Chief Executive Officer
Table II: Derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-10 | Returned to the company : show line 1 in the form Stock Option (right to buy) | −4,750 | $0.04 | $176 | 0 | D |
| 2025-04-10 | Returned to the company : show line 2 in the form Stock Option (right to buy) | −3,750 | $0.04 | $139 | 0 | D |
| 2025-04-10 | Returned to the company : show line 3 in the form Stock Option (right to buy) | −813 | $0.04 | $30 | 0 | D |
| 2025-04-10 | Returned to the company : show line 4 in the form sStock Option (right to buy) | −1,500 | $0.04 | $56 | 0 | D |
| 2025-04-10 | Returned to the company : show line 5 in the form Stock Option (right to buy) | −1,563 | $0.04 | $58 | 0 | D |
| 2025-04-10 | Returned to the company : show line 6 in the form Stock Option (right to buy) | −1,250 | $0.04 | $46 | 0 | D |
Loading xslF345X05/ownership.xml…